Junya Kanda

講師 / Senior Lecturer/ Junior Associate Professor

Kyoto University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

ORCID

Google Scholar

Academic Page

About

Junya Kanda is a Senior Lecturer and Junior Associate Professor at Kyoto University in Japan. His research areas include hematopoietic stem cell transplantation, CAR-T cell therapy, and the implications of genetic mutations in hematological malignancies. Recent publications focus on optimizing stem cell transplantation techniques and improving outcomes in patients with various blood cancers. He contributes significantly to the understanding of patient outcomes in chimeric antigen receptor T cell therapies and the effects of clinical practices within transplantation centers.

Junya Kanda

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Yield-driven approach optimizes apheresis of CD19 chimeric antigen receptor-T cell therapy for patients with lymphoma

Effectiveness of posaconazole as primary prophylaxis in allogeneic hematopoietic stem cell transplantation

Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post‐CAR‐T‐cell therapy

Has early mortality following single‐unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan

Prolonged chimeric antigen receptor‐T apheresis to infusion time is associated with inferior outcomes in diffuse large B‐cell lymphoma

Center effect on outcomes of second allogeneic hematopoietic stem cell transplantation for B-cell acute lymphoblastic leukemia: a nationwide retrospective study

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms

Impact of center volume on outcomes in allogeneic hematopoietic cell transplantation for children

Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML

Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrow

The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients

Impact of Early Cytomegalovirus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients With Myelodysplastic Syndrome: A Nationwide Retrospective Study From Adult Myelodysplastic Syndrome Working Group of the JSTCT

KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis

Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan

Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry

Successful Second CBT for Graft Failure After First CBT for Adult-Onset Familial Hemophagocytic Lymphohistiocytosis Type 3: A Case Report

Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry

Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning

Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide

Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy

Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations

Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment

Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy

Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy

An adult case of refractory autoimmune neutropenia after liver transplantation

Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation

Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy

Collaborators (13)

Tatsuya Konishi

Takaaki Konuma

Yotaro Ochi

TAKASHI IKEDA

Tomoyasu Jo

Eisei Kondo

Yasuyuki Arai

JUNYA KURODA

Yutaka Shimazu

Nobuhiko Nakamura

Keitaro Matsuo

Ritsuro Suzuki

Akifumi Takaori‐Kondo

How do I reach out?

Meet Kite AI